Uptake of iodine-123-α-methyl tyrosine by gliomas and non-neoplastic brain lesions

European Journal of Nuclear Medicine

Volumn 23, Issue 10, 1996, Pages 1345-1353

  Kuwert, Torsten ^a   Morgenroth, Carlo ^a   Woesler, Burkhard ^a   Matheja, Peter ^a   Palkovic, Stefan ^a   Vollet, Bernhard ^a   Samnick, Samuel ^a   Maasjosthusmann, Ulrich ^a   Lerch, Hartmut ^a   Gildehaus, Franz Josef ^a   Wassmann, Hansdetlef ^a   Schober, Otmar ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Amino acids; Brain neoplasms; Iodine 123 methyl tyrosine; Radionuclide imaging; Single photon emission tomography

Indexed keywords

AMINO ACID; FLUORODEOXYGLUCOSE F 18; IODINE 123; METIROSINE;

ADULT; AGED; AMINO ACID TRANSPORT; ARTICLE; BRAIN HEMATOMA; BRAIN INFARCTION; BRAIN TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; BRAIN; BRAIN DISEASES; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOMA; HUMANS; IODINE RADIOISOTOPES; MALE; METHYLTYROSINES; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 10244249232     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01367590     Document Type: Article

References (52)

1. Herholz K. Tracers for clinical evaluation of gliomas: a neurologist's view. In: Mazoyer BM, Heiss WD, Comar D, eds. PET studies on amino acid metabolism and protein synthesis. Dordrecht: Kluwer Academic; 1993: 203-214.
2. Leeds NE, Jackson EF. Current imaging techniques for the evaluation of brain neoplasms. Curr Opin Oncol 1994; 6: 254-261.
3. Conti PS. Introduction to imaging brain tumor metabolism with positron emission tomography. Cancer Invest 1995; 13: 244-259.
4. 123I]Iodo-α-methyl tyrosine and SPET. J Nucl Med 1989; 30: 110-112.
5. 124IMT. J Nucl Med 1990; 31: 281-286.
6. 123I]iodo-α-methyl-tyrosine: competition with natural L-amino acids. J Nucl Med 1991; 32: 1225-1228.
7. Kawai K, Fujibayashi Y, Saji H, Yonekura Y, Konishi J, Kubodera A, Yokoyama A. A strategy for the study of cerebral amino acid transport using an iodine-123-labelled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine. J Nucl Med 1991; 32: 819-824.
8. 123I-Jod-α-Methyltyrosin in Hurntumorrezidiven. Nucl Med 1995; 34: 71-75.
9. Zülch KJ. Principles of the new World Health Organisation (WHO) classification. Neuroradiology 1980; 19: 59-66.
10. 123(125)Xe-exposed KIO3, a reagent for iodination with high specific activity. Radioclin Acta 1977; 24: 42-46.
11. Fischer S, Wolf H, Brandau W, Clausen M, Henze E, Schober O. Iodierung von α-Methyltyrosin (AMT): Optimierung der Methode für die Routinepräparation. Nucl Med 1993; 32: A113.
12. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kiliänen H. Physical performance of the Siemens Multi SPET 3 gamma camera. Nucl Med Commun 1993; 14: 490-497.
13. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; NS-26/2: 2780-2789.
14. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Schäfers M, Wassmann H, Schober O. Influence of size of regions of interest on the measurement of uptake of iodine-123-α-methyl thyrosine by brain tumours. Nucl Med Commun 1996; 17: 609-615.
15. Bortz J. Lehrbuch der Statistik, 2nd edn. Berlin Heidelberg New York: Springer, 1985.
16. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995; 195: 47-52.
17. Müller SP, Reiners C. Studies and recommendations on the design of ROC analyses in nuclear medicine. Nucl Med 1995; 34: 24-41.
18. Herholz K, Ziffling P, Staffen W, et al. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET. Eur J Cancer Clin Oncol 1988; 24: 1139-1150.
19. 18F)fluorotyrosine. J Nucl Med 1991; 32: 1338-1346.
20. Schober O, Meyer G-J, Stolke D, Hundeshagen H. Brain tumor imaging using C-11-laelled L-methionine and D-methionine. J Nucl Med 1985; 26: 98-99.
21. 11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 1987; 28: 225-229.
22. Ishiwata K, Kubota K, Murakami M, Kubota R, Sasaki T, Ishii S, Senda M. Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 1993; 34: 1936-1943.
23. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985; 62: 816-822.
24. 18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323-1329.
25. Patronas NJ, Brooks RA, DeLaPaz RL, Smith BH, Kornblith PL, Di Chiro G. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR 1983; 4:533-535.
26. Kim CK, Alavi JB, Alavi A, Reivich M. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 1991; 10: 85-91.
27. 11C]L-Methionine uptake in gliomas. Neurosurgery 1989; 30: 225-232.
28. Ogawa , T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186: 45-53.
29. Byrne TN. Imaging of gliomas. Semin Oncol 1994; 21: 162-171.
30. Butler AR, Horii SC, Krichef I, et al. Computed tomography in astrocytomas. A statistical analysis of the parameters of malignancy and the positive contrast-enhanced CT scan. Radiology 1978; 129: 433-439.
31. 125I]iodo-alpha-methyl-L-tyrosine. Nucl Med Biol 1995; 22: 309-313.
32. Dethy S, Goldman S, Blecic S, Luxen A, Levivier M, Hildebrand J. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med 1994; 35: 1162-1166.
33. 11C-methyl-methionine uptake in ischemically compromised brain tissue. J Cereb Blood Flow Metab 1995; 15 Suppl 1: S673.
34. Welsh FA, Moyer DJ, Harris VA. Regional expression of heat shock protein-70 mRNA and c-fos mRNA following focal ischemia in rat brain. J Cereb Blood Flow Metab 1992; 12: 204-212.
35. 11C]methionine uptake in brain abscess: a PET study. J Comput Assist Tomogr 1993; 17: 660-661.
36. 18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr 1990; 14: 486-487.
37. Newsholme P, Newsholme EA. Rates of utilization of glucose, glutamine, and oleate and formation of end-products by mouse peritoneal macrophages in culture. Biochem J 1989; 261: 211-218.
38. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.
39. Kubota R, Kubota K, Yamada S, Tada M, Takahashi T, Iwata R, Tamahashi N. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995; 36: 484-492.
40. Herholz K, Pietrzyk U, Voges J, Schröder R, Halber M, Treuer H, Sturm V, Heiss W-D. Correlation of glucose consumption and tumor cell density in astrocytomas. J Neurosurg 1993; 79: 853-858.
41. Dooms GC, Hecht S, Brant-Zawadzki M, et al. Brain radiation lesions: MR imaging. Radiology 1986; 158: 149-155.
42. Di Chiro G, Oldfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors. AJR 1988; 150: 189-197.
43. Lilja A, Lundquist H, Olsson Y, et al. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment induced brain lesions. Acta Radiol 1989; 30: 121-128.
44. 18F]-fluorodeoxyglucose positron emission tomography. Ann Neurol 1991; 29: 347-355.
45. 11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991; 32: 197-202.
46. 18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 1993; 33: 540-548.
47. 18F-fluorodeoxyglucose PET. AJR 1994; 163: 1459-1465.
48. Mosskin S, Ericson K, Hindmarsh T, et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 1989; 30: 225-232.
49. Ancri D, Bassett JY. Diagnosis of cerebral lesions by thallium-201. Radiology 1978; 128: 417-422.
50. Maffioli L, Gasparini M, Chiti A, Gramaglia A, Mongioj V, Pozzi A, Bombardieri E. Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumors. Eur J Nucl Med 1996; 23: 308-311.
51. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
52. Oriuchi N, Tomiyoshi K, Inoue T, et al. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 1996; 37: 457-462.